Supplementary Figure S1 from Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer

Authors :: Josep Tabernero
Anthony W. Tolcher
Eric Van Cutsem
Stephan Braun
Ivan D. Horak
Michael Kragh
Mikkel W. Pedersen
Rikke Hald
Ulla H. Hansen
Niels J.Ø. Skartved
Guillem Argilés
Rachel S. van der Post
Bastiaan B.J. Tops
Susana Roselló
Marta Benavent
Andrés Cervantes
Rocio Garcia-Carbonero
Amita Patnaik
Rodrigo Dienstmann
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure S1. Pharmacokinetic profile of Sym004.

Tools